Table 1. Characteristics of the included studies.
First author | Year | Country | Tumor type | Sample | Reference | Detection method | Sample size | Outcome | Cut-off value |
---|---|---|---|---|---|---|---|---|---|
Kaihua Lu [22] | 2013 | China | NSCLC | tissue | GAPDH | q-PCR | 44 | OS | 0.27 |
Ming Sun [23] | 2014 | China | GC | tissue | GAPDH | q-PCR | 72 | OS | 0.377-fold |
Lingfei Jia [24] | 2014 | China | TSCC | tissue | β-actin | q-PCR | 76 | OS | mean |
Zhenye Li [27] | 2014 | China | NFPAs | tissue | GAPDH | q-PCR | 52 | — | median |
Han Zhuo [25] | 2015 | China | HCC | tissue | GAPDH | q-PCR | 72 | OS, RFS | median |
Zhizhong Tian [26] | 2015 | China | osteosarcoma | tissue | GAPDH | q-PCR | 64 | OS | median |
Gang Luo [28] | 2015 | China | PC | tissue | GAPDH | q-PCR | 21 | — | NA |
Feifei Meng [30] | 2016 | China | GC | tissue | GAPDH | q-PCR | 55 | OS | NA |
Weili Duan [29] | 2016 | China | BC | tissue | GAPDH | q-PCR | 80 | RFS | median |
NSCLC: non-small cell lung cancer, GC: gastric cancer (GC), TSCC: tongue squamous cell carcinoma, NFPAs: non-functioning pituitary adenomas, HCC: hepatocellular carcinoma, PC: prostate cancer (PC), BC: bladder cancer; OS: overall survival; RFS: recurrence-free survival.